The UK’s Advanced Research and Innovation Agency (ARIA), launched in 2023, is investing over £1 billion in high-risk, high-reward projects, including a £69 million initiative to develop precise neurotechnologies for brain disorders like epilepsy and Alzheimer’s. These conditions cost the UK economy billions annually. ARIA aims to create technologies that can interface with brain circuits more accurately. Currently, 19 teams are exploring innovative ideas, such as using ultrasound to study and treat brain circuitry. One project at Imperial College London combines ultrasound and gene therapy to image gene expression in neurons, offering insights into malfunctioning brain networks. Techniques like deep brain stimulation, already used for Parkinson’s, could potentially treat other conditions like depression and addiction. This research could revolutionize neurotherapeutics by providing new treatments for various neurological disorders.
QUESTION: How might advancements in neurotechnology change the way we understand and treat mental health conditions in the future?
The UK’s Answer to Darpa Wants to Rewire the Human Brain
